Perfect Corp. Reports Unaudited Financial Results for the Three Months and the Six Months Ended June 30, 2025
NEW YORK–(BUSINESS WIRE)–Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”)
NEW YORK–(BUSINESS WIRE)–Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”)
Nearly US$20,000 Prize Pool and 100 Exclusive Rewards for Top Developers Participants use Tencent Cloud
Award-winning videos highlight PDS Health’s integrated care platform and celebrate regional teamwork through creative storytelling
NEW YORK, July 28, 2025 /PRNewswire/ — Paramount Global (NASDAQ: PARA, PARAA) announced today that
SANTA CLARA, Calif., July 28, 2025 /PRNewswire/ — Meshy.ai, a leading AI-driven platform for 3D
Animon Studio Makes Professional Anime Creation and Storytelling Accessible to All TOKYO, July 28, 2025
The new location serving a full menu of breakfast, brunch and lunch opens its doors
Integration Bridges the Gap Between Manual Processes and Data Entry Into ERP Systems, Cutting Turnaround
Advanced robotics to accelerate propagation, reduce carbon footprint, and scale plant-based materials faster than ever
VIRGINIA BEACH, VA / ACCESS Newswire / July 28, 2025 / Cedar Realty Trust, Inc.
DELRAY BEACH, FL / ACCESS Newswire / July 28, 2025 / Headwall Partners LLC (“Headwall”),
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe
Even after death, IRS debt can follow – Clear Start Tax warns surviving spouses about
Proposed Merger of Regional Health Properties, Inc. (“Regional” or “the Company”) with SunLink Health Systems,
HALIFAX, NS / ACCESS Newswire / July 28, 2025 / Namibia Critical Metals Inc. (“Namibia
MIAMI BEACH, FL / ACCESS Newswire / July 28, 2025 / C2 Blockchain Inc. (OTC:CBLO),
Netsmart ranks as top EHR software in 2025’s Top HIT Vendor for Inpatient Behavioral Health
Conversation will feature visionary crypto leaders Ryan Zurrer of Dialectic, Robert Leshner of Superstate, and
– Of 34 CMML treatment-naïve participants enrolled and treated with lenzilumab plus azacitidine, 22 have
Parties negotiating terms of definitive agreement Supports XCF’s plan to become the leading fully integrated